Healthcare -
Biotechnology - NASDAQ - US
$ 1.5946
-13 %
$ 113 M
Market Cap
-0.93
P/E
CCCC - REVENUE
Revenue CCCC - C4 Therapeutics, Inc.
35.6 M
LAST VALUE
6.97%
2 YEAR CAGR
10.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR